Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function
Levon M. Khachigian
Levon M. Khachigian
Published November 15, 2000
Citation Information: J Clin Invest. 2000;106(10):1189-1195. https://doi.org/10.1172/JCI11620.
View: Text | PDF
Perspective

Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function

  • Text
  • PDF
Abstract

Authors

Levon M. Khachigian

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Model of Egr-1–dependent response to injury. Injury to vascular cells re...
Model of Egr-1–dependent response to injury. Injury to vascular cells releases preformed endogenous growth factors (such as FGF-2), which activate Egr-1 gene expression in a paracrine manner via mitogen-activated protein kinases (MAPKs). Egr-1 protein can, in certain promoters, displace Sp1 from overlapping binding sites and increase the expression of pathophysiologically relevant genes whose products contribute to neointima formation. Rec, receptor.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts